You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

Impact Factor: 1.7 / 5-Year Impact Factor: 1.7

Journal Homepage Submission guidelines

Restricted access

Letter

First published online 2010-3

Controversial Topics

Volume 143, Issue 2

https://doi.org/10.3821/1913-701X-143.2.60

Abstract

Get full access to this article

View all access options for this article.

References

1.

Lynas

K.

Natural health products industry claims Canadian standards for product licensing threaten consumer choice and industry viability. Can Pharm J 2009;142:277.

2.

Lynas

K.

Most drugs approved by Health Canada not declared eligible for provincial drug plan coverage: Fraser Institute. Can Pharm J 2009;142:279.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

New Generic Pricing Rules Come to Newfoundland and Labrador and New Brunswick

Retricted access

Pharmacological evaluation of methanolic leaf extract of Swietenia mahagoni on acrylamide-induced neuropathic pain in rats

Retricted access

University of Waterloo Celebrates Innovation and Entrepreneurship

Retricted access

Monoclonal Antibody That Recognizes a Domain on Heterogeneous Nuclear Ribonucleoprotein K and PTB-Associated Splicing Factor